0543400327/0556089201

helixafe: cancer driver interception

HELIXAFE investigates the initial genetic imbalance stage that precedes the formation of tumours and can last up to 5-15 years.

Why HELIXAFE Can Prevent Cancer?

Every day, our DNA is damaged thousands of times by natural causes and external factors (alcohol, drugs, pollution, hormones, smoking, unhealthy food, radiation, stress….)

Our body repairs these damages by using a body function focused on monitoring and maintaining the DNA integrity. In case of deficiency of this function, the DNA cannot be repaired, so the damages are progressively accumulated. The progressive accumulation of these unrepaired damages (somatic mutations) is an initial stage in the development of tumours when people are still healthy and don’t have any symptoms.

HELIXAFE investigates the initial genetic imbalance stage that precedes the formation of tumours and can last up to 5-15 years.

HELIXAFE assessment is based on a recently discovered technology which requires a simple blood sample and investigates the real conditions of the DNA in relation to the possible development of a tumour. It does not check hereditary predisposition as other genetic tests.

Who Should Do HELIXAFE?

  • Stress
  • Chronic diseases
  • Exposure to chemicals
  • History of smoking
  • Exposure to pollution
  • Intestinal disorders
  • Alcohol consumption
  • Viral and bacterial infection
  • Hormone therapy
  • Overexposure to the sun
  • Allergies
  • Family history of cancer
  • Chronic inflammation
  • Exposure to radiation
  • Food additives

HELIXAFE Prevention Program

To assess the progressive accumulation of DNA damage, the test must be repeated regularly.

The Cancer Driver Condition can always be treated with biopreventive agents and targeted interventions that repair DNA damage and cancer development.

There is a second level of cancer prevention programs that allows to provide in-depth investigation in the conditions related to breast/ovarian, lung and colon cancer.

Copyright ©2022. MedCells International FZ LLC

Go Back to Regenerative Medicine